These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21407233)

  • 1. Regenerative medicine for skin diseases: iPS cells to the rescue.
    Uitto J
    J Invest Dermatol; 2011 Apr; 131(4):812-4. PubMed ID: 21407233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revertant mosaicism in the skin.
    Lai-Cheong JE; McGrath JA
    G Ital Dermatol Venereol; 2013 Feb; 148(1):73-82. PubMed ID: 23407079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous mosaicism: right before our eyes.
    Frank J; Happle R
    J Clin Invest; 2007 May; 117(5):1216-9. PubMed ID: 17476352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?
    Tamai K; Uitto J
    J Invest Dermatol; 2016 Nov; 136(11):2119-2121. PubMed ID: 27772543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa.
    Tolar J; Blazar BR; Wagner JE
    Stem Cells; 2011 Jun; 29(6):900-6. PubMed ID: 21557391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa: prospects for cell-based therapies.
    Uitto J
    J Invest Dermatol; 2008 Sep; 128(9):2140-2. PubMed ID: 18695685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
    Salewski RP; Eftekharpour E; Fehlings MG
    J Cell Physiol; 2010 Mar; 222(3):515-21. PubMed ID: 20020443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidermolysis bullosa: first genetic stem cell therapy is successful].
    Jung H
    Kinderkrankenschwester; 2007 Jan; 26(1):23. PubMed ID: 17294789
    [No Abstract]   [Full Text] [Related]  

  • 11. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The joint battle to tackle epidermolysis bullosa through gene therapy.
    De Rosa L; De Luca M
    Trends Mol Med; 2022 Jul; 28(7):533-535. PubMed ID: 35599142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015.
    Uitto J; Bruckner-Tuderman L; Christiano AM; McGrath JA; Has C; South AP; Kopelan B; Robinson EC
    J Invest Dermatol; 2016 Feb; 136(2):352-358. PubMed ID: 26802230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac regeneration: still a 21st century challenge in search for cardiac progenitors from stem cells and embryos.
    Neri T; Stefanovic S; Pucéat M
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):16-21. PubMed ID: 20631550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease.
    Abeliovich A; Doege CA
    Neuron; 2009 Feb; 61(3):337-9. PubMed ID: 19217371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured epidermal stem cells in regenerative medicine.
    Jackson CJ; Tønseth KA; Utheim TP
    Stem Cell Res Ther; 2017 Jul; 8(1):155. PubMed ID: 28676094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From skin cells to hepatocytes: advances in application of iPS cell technology.
    Greenbaum LE
    J Clin Invest; 2010 Sep; 120(9):3102-5. PubMed ID: 20739747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.